Alex V. Soriano
Expertise in
20
conditions

Alex V. Soriano

Barcelona, CT, ES 
Expertise in
20
conditions
Barcelona, CT, ES 

Overview

Alex Soriano practices practicing medicine in Barcelona, Spain.

Mr. Soriano is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Sepsis, Pneumonia, Febrile Neutropenia, Hip Replacement, and Knee Replacement.

He is actively involved in clinical research, co-authoring 409 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Barcelona, CT, Spain
Other Locations
Madrid, MD, Spain
Valencia, VC 46022, Spain
Paterna, VC 46980, Spain
Santa Cruz De Tenerife, CN, Spain
Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase IIb/III, Open Label, Single Arm, Multi-centre, Trial to Assess the Immunogenicity and Safety of an Additional Dose Vaccination With a Recombinant Protein RBD Fusion Heterodimer Candidate (PHH-1V) Against SARS-CoV-2, in Adults With Pre-existing Immunosuppressive Conditions Vaccinated Against COVID-19
A Phase IIb/III, Open Label, Single Arm, Multi-centre, Trial to Assess the Immunogenicity and Safety of an Additional Dose Vaccination With a Recombinant Protein RBD Fusion Heterodimer Candidate (PHH-1V) Against SARS-CoV-2, in Adults With Pre-existing Immunosuppressive Conditions Vaccinated Against COVID-19
Enrollment Status: Completed
Publish Date: September 16, 2025
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Multi-centre, Multi-country Retrospective Cohort Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
A Multi-centre, Multi-country Retrospective Cohort Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia
Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drugs: Siltuximab, Methylprednisolone
Study Phase: Phase 2
A Phase I/IIa Study to Evaluate Safety and Immunogenicity of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers
A Phase I/IIa Study to Evaluate Safety and Immunogenicity of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers
Enrollment Status: Completed
Publish Date: March 01, 2023
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization
Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization
Enrollment Status: Completed
Publish Date: August 23, 2022
Intervention Type: Drug
Study Phase: Phase 1
Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19).
Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19).
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Other, Drug
Study Drug: Maraviroc
Study Phase: Phase 2
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Enrollment Status: Completed
Publish Date: May 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized Multicenter Study to Assess Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bacteremia in Hospitalized Patients
Randomized Multicenter Study to Assess Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bacteremia in Hospitalized Patients
Enrollment Status: Completed
Publish Date: January 17, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

409 Total Publications

Assessment of the risk of bacteremia in patients with hematologic malignancies in the emergency department: A comparative study between logistic regression and machine learning algorithms.
Assessment of the risk of bacteremia in patients with hematologic malignancies in the emergency department: A comparative study between logistic regression and machine learning algorithms.
Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
Published: March 25, 2026

Frequently Asked Questions about Alex V. Soriano

Is Alex V. Soriano a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Alex V. Soriano is classified as an Elite expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alex V. Soriano participate in research or clinical trials?

Yes. Alex V. Soriano has published 409 articles and abstracts on conditions like Sepsis. You can view a list of Alex V. Soriano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Soriano's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 9 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile